| Human CYP2B6: expression, inducibility and catalytic activities L Gervot, B Rochat, JC Gautier, F Bohnenstengel, H Kroemer, ... Pharmacogenetics and Genomics 9 (3), 295-306, 1999 | 328 | 1999 |
| Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation? B Rochat, JM Morsman, GI Murray, WD Figg, HL McLeod Journal of Pharmacology and Experimental Therapeutics 296 (2), 537-541, 2001 | 242 | 2001 |
| Therapeutic drug monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry A Haouala, B Zanolari, B Rochat, M Montemurro, K Zaman, MA Duchosal, ... Journal of Chromatography B 877 (22), 1982-1996, 2009 | 236 | 2009 |
| Population pharmacokinetics of imatinib and the role of α1‐acid glycoprotein N Widmer, LA Decosterd, C Csajka, S Leyvraz, MA Duchosal, A Rosselet, ... British journal of clinical pharmacology 62 (1), 97-112, 2006 | 216 | 2006 |
| Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism B Rochat Clinical pharmacokinetics 44, 349-366, 2005 | 167 | 2005 |
| Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole … LA Decosterd, B Rochat, B Pesse, T Mercier, F Tissot, N Widmer, J Bille, ... Antimicrobial agents and chemotherapy 54 (12), 5303-5315, 2010 | 153 | 2010 |
| Identification of three cytochrome P450 isozymes involved in N-demethylation of citalopram enantiomers in human liver microsomes B Rochat, M Amey, M Gillet, UA Meyer, P Baumann Pharmacogenetics and Genomics 7 (1), 1-10, 1997 | 152 | 1997 |
| Analysis of enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients using chiral reverse-phase liquid chromatography B Rochat, M Amey, P Baumann Therapeutic drug monitoring 17 (3), 273-279, 1995 | 148 | 1995 |
| A LC–tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine A Fayet, A Béguin, B Zanolari, S Cruchon, N Guignard, A Telenti, ... Journal of Chromatography B 877 (11-12), 1057-1069, 2009 | 146 | 2009 |
| Comparison between a high‐resolution single‐stage Orbitrap and a triple quadrupole mass spectrometer for quantitative analyses of drugs H Henry, HR Sobhi, O Scheibner, M Bromirski, SB Nimkar, B Rochat Rapid Communications in Mass Spectrometry 26 (5), 499-509, 2012 | 140 | 2012 |
| Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood … S Colombo, A Beguin, A Telenti, J Biollaz, T Buclin, B Rochat, ... Journal of Chromatography B 819 (2), 259-276, 2005 | 137 | 2005 |
| Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror P Baumann, B Rochat International clinical psychopharmacology 10, 15-22, 1995 | 127 | 1995 |
| Ultra-high pressure liquid chromatography–mass spectrometry for plant metabolomics: A systematic comparison of high-resolution quadrupole-time-of-flight and single stage … G Glauser, N Veyrat, B Rochat, JL Wolfender, TCJ Turlings Journal of Chromatography A 1292, 151-159, 2013 | 112 | 2013 |
| Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver B Rochat, M Kosel, G Boss, B Testa, M Gillet, P Baumann Biochemical pharmacology 56 (1), 15-23, 1998 | 112 | 1998 |
| Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term M Neef, M Ledermann, H Saegesser, V Schneider, N Widmer, ... Journal of hepatology 44 (1), 167-175, 2006 | 107 | 2006 |
| Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation G Bondolfi, C Chautems, B Rochat, G Bertschy, P Baumann Psychopharmacology 128, 421-425, 1996 | 100 | 1996 |
| From targeted quantification to untargeted metabolomics: Why LC-high-resolution-MS will become a key instrument in clinical labs B Rochat TrAC Trends in Analytical Chemistry 84, 151-164, 2016 | 99 | 2016 |
| Analysis and quantification of vitamin D metabolites in serum by ultra‐performance liquid chromatography coupled to tandem mass spectrometry and high‐resolution mass … SJ Bruce, B Rochat, A Béguin, B Pesse, I Guessous, O Boulat, H Henry Rapid Communications in Mass Spectrometry 27 (1), 200-206, 2013 | 92 | 2013 |
| Transport mechanisms for the antidepressant citalopram in brain microvessel endothelium B Rochat, P Baumann, KL Audus Brain research 831 (1-2), 229-236, 1999 | 88 | 1999 |
| Determination of imatinib (Gleevec®) in human plasma by solid-phase extraction–liquid chromatography–ultraviolet absorbance detection N Widmer, A Béguin, B Rochat, T Buclin, T Kovacsovics, MA Duchosal, ... Journal of Chromatography B 803 (2), 285-292, 2004 | 87 | 2004 |
